
- Published
- Updated
Sponsor review in a publication agreement can help identify accuracy or confidentiality issues. Commercial expectations must not become a mechanism for selecting favourable findings, however. Explicit roles for comments, approval and contribution support trustworthy communication of trial results and make the reasons for revisions understandable.
Decision framework
Separate data provenance, scientific assessment, author contributions and commercial confidentiality review in the publication plan. Appropriate legal and scientific owners should assess agreement provisions. This article prescribes no particular publication right or standard review period. Records should explain which revisions were requested for evidence-based reasons.
Worked example
For example, a draft reports no expected benefit, while a commercial team wants a more favourable subgroup interpretation highlighted. Scientific reviewers assess consistency with the analysis plan and findings and explain the interpretation's limitations. Prerelease review is not transformed into a way to suppress inconvenient results, and material discussion is documented.
Implementation checks
- Distinguish comments about scientific accuracy, clarity and confidentiality, recording the reason for each significant requested change.
- Link important revisions in the draft to the supporting data or analytical rationale so their basis remains traceable.
- Establish separate authorised routes for scientific disagreement and contractual interpretation rather than allowing one to obscure the other.
Acceptance and boundaries
Accept the process when the account presented to readers reflects the strength and limitations of evidence honestly. Relevant journal and specialist guidance should inform authorship and publication ethics separately. Negative or uncertain findings deserve the same seriousness in reliable reporting as favourable findings arising from the trial.
Frequently asked questions
- Can a sponsor comment on a manuscript?
- Within its role and agreement, yes; scientific comments should be evidence-based and traceable.
- Must every comment be implemented?
- No. Appropriate reviewers should assess the rationale and scientific consistency, then document their decision.